1473 related articles for article (PubMed ID: 28832905)
1. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
[TBL] [Abstract][Full Text] [Related]
2. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
[TBL] [Abstract][Full Text] [Related]
3. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Broderick C; Yeoh SE; Stansby G
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD010837. PubMed ID: 34597414
[TBL] [Abstract][Full Text] [Related]
4. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2015 Mar; (3):CD010837. PubMed ID: 25749503
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet agents for the treatment of deep venous thrombosis.
Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
[TBL] [Abstract][Full Text] [Related]
6. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Robertson L; Yeoh SE; Ramli A
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular electrical stimulation for the prevention of venous thromboembolism.
Hajibandeh S; Hajibandeh S; Antoniou GA; Scurr JR; Torella F
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011764. PubMed ID: 29161465
[TBL] [Abstract][Full Text] [Related]
8. Home versus in-patient treatment for deep vein thrombosis.
Othieno R; Okpo E; Forster R
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
[TBL] [Abstract][Full Text] [Related]
9. Pentasaccharides for the prevention of venous thromboembolism.
Dong K; Song Y; Li X; Ding J; Gao Z; Lu D; Zhu Y
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005134. PubMed ID: 27797404
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
11. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
Herlihy DR; Thomas M; Tran QH; Puttaswamy V
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD010525. PubMed ID: 32692430
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
[TBL] [Abstract][Full Text] [Related]
13. Vena caval filters for the prevention of pulmonary embolism.
Young T; Sriram KB
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD006212. PubMed ID: 33027844
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
Andras A; Sala Tenna A; Stewart M
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834
[TBL] [Abstract][Full Text] [Related]
15. Pentasaccharides for the treatment of deep vein thrombosis.
Brandao GM; Junqueira DR; Rollo HA; Sobreira ML
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011782. PubMed ID: 29199766
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
Forster R; Stewart M
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
[TBL] [Abstract][Full Text] [Related]
17. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism.
Li M; Li J; Wang X; Hui X; Wang Q; Xie S; Yan P; Tian J; Li J; Xie P; Yang K; Yao L
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010957. PubMed ID: 37057837
[TBL] [Abstract][Full Text] [Related]
18. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Jones LE
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001100. PubMed ID: 28182249
[TBL] [Abstract][Full Text] [Related]
19. Treatment of distal deep vein thrombosis.
Kirkilesis G; Kakkos SK; Bicknell C; Salim S; Kakavia K
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013422. PubMed ID: 32271939
[TBL] [Abstract][Full Text] [Related]
20. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.
Kakkos SK; Caprini JA; Geroulakos G; Nicolaides AN; Stansby G; Reddy DJ; Ntouvas I
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD005258. PubMed ID: 27600864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]